InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today annou

GlobeNewswireApr 3 20:59

InspireMD Boosts Executive Severance Benefits Ahead of Potential Takeover

TipRanksApr 2 21:22

InspireMD's (NASDAQ:NSPR) Investors Will Be Pleased With Their Solid 110% Return Over the Last Year

Yahoo FinanceMar 31 21:08

InspireMD to Present Key Trial Results at LINC 2024

TipRanksMar 26 20:12

InspireMD Announces Abstract Of One-year Follow-up Results From C-GUARDIANS U.S. Investigational Device Exemption Clinical Trial Accepted For Presentation At LINC 2024

InspireMD Announces Abstract Of One-year Follow-up Results From C-GUARDIANS U.S. Investigational Device Exemption Clinical Trial Accepted For Presentation At LINC 2024

BenzingaMar 26 19:13

Earnings Call Summary | InspireMD(NSPR.US) Q4 2023 Earnings Conference

The following is a summary of the InspireMD Inc. (NSPR) Q4 2023 Earnings Call Transcript:Financial Performance:InspireMD reported Q4 revenue increase of 71.6% to $1.76 million, significantly driven by

Futu NewsMar 7 01:11 · Conference Call